NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)

Summary

The purpose of this study is to evaluate the safety and effectiveness of NasoVAX in preventing worsening of symptoms and hospitalization in patients with early COVID-19.

Timeline

Start

2020-10-10

Primary completion

2021-02-15

Completion

2021-02-15

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment”

Drugs

Indications